Can Clinical Predictive Models Identify Patients Who Should Not Receive TAVR? A Systematic Review
{{output}}
Background: One third of high- and prohibitive-risk TAVR patients remain severely symptomatic or die 1 year after treatment. There is interest in identifying individuals for whom this procedure is futile and should not be offered... ...
